See Hims & Hers Health's analyst price targets ($31) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$28.77
10 analysts in the last 4 months
High: $40 | Low: $23
No recommendations in the last 4 months.
Hims & Hers Health (HIMS) currently reports a target price of $31. Use the charts on this page to explore Hims & Hers Health's target price history and peer comparisons.
Analysts' average 12-month price target for Hims & Hers Health is $31, about 6.2% upside from the current share price of $28.77. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $31, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hims & Hers Health, and consider following HIMS for alerts when major investors trade the stock.
Hims & Hers Health is classified in the Consumer Staples sector. On target price, it currently shows $31. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing HIMS with unrelated industries.